These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22306350)

  • 1. Monoclonal antibodies for chronic refractory asthma and pipeline developments.
    Polosa R; Casale T
    Drug Discov Today; 2012 Jun; 17(11-12):591-9. PubMed ID: 22306350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies for the treatment of asthma.
    Catley MC; Coote J; Bari M; Tomlinson KL
    Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting interleukins to treat severe asthma.
    Gibeon D; Menzies-Gow AN
    Expert Rev Respir Med; 2012 Aug; 6(4):423-39. PubMed ID: 22971067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of monoclonal antibodies in the treatment of severe asthma.
    Tourangeau LM; Kavanaugh A; Wasserman SI
    Ther Adv Respir Dis; 2011 Jun; 5(3):183-94. PubMed ID: 21393345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A
    Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies for the treatment of severe asthma.
    Clienti S; Morjaria JB; Basile E; Polosa R
    Curr Allergy Asthma Rep; 2011 Jun; 11(3):253-60. PubMed ID: 21360131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin E blockade in the treatment of asthma.
    Kuhn R
    Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P; Hauser C; Rochat T
    Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma.
    Caruso M; Crisafulli E; Demma S; Holgate S; Polosa R
    Expert Opin Biol Ther; 2013 Mar; 13(3):393-402. PubMed ID: 23289846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapeutics for severe refractory asthma: monoclonal antibodies.
    Grainge CL; Maltby S; Gibson PG; Wark PA; McDonald VM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):927-41. PubMed ID: 27018798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J; Cabrera P; Berkman N; Buhl R; Holgate S; Wenzel S; Fox H; Hedgecock S; Blogg M; Cioppa GD
    Allergy; 2005 Mar; 60(3):302-8. PubMed ID: 15679714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic effects of suboptimally controlled asthma.
    Bootman JL; Crown WH; Luskin AT
    Manag Care Interface; 2004 Jan; 17(1):31-6. PubMed ID: 15035598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgE in severe persistent allergic asthma.
    Fox H
    Respirology; 2007 Nov; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe asthma: new therapeutic targets].
    Aubier M
    Bull Acad Natl Med; 2010 Jun; 194(6):1009-19. PubMed ID: 21513135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Antibodies for the Management of Severe Asthma.
    Rubinsztajn R; Chazan R
    Adv Exp Med Biol; 2016; 935():35-42. PubMed ID: 27334730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving from an asthma pipe dream to a pipeline.
    Holmes D
    Nat Rev Drug Discov; 2012 Oct; 11(10):737-8. PubMed ID: 23023668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.